|
LIN9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.291000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.163600E-02 |
| Normal-vs-Stage2 |
9.788800E-01 |
| Normal-vs-Stage3 |
2.462800E-01 |
| Normal-vs-Stage4 |
4.037400E-01 |
| Stage1-vs-Stage2 |
3.602200E-01 |
| Stage1-vs-Stage3 |
1.709540E-02 |
| Stage1-vs-Stage4 |
2.660400E-01 |
| Stage2-vs-Stage3 |
3.617800E-01 |
| Stage2-vs-Stage4 |
4.125400E-01 |
| Stage3-vs-Stage4 |
6.645800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.974800E-01 |
| Normal-vs-AfricanAmerican |
7.272400E-01 |
| Normal-vs-Asian |
8.642400E-01 |
| Caucasian-vs-AfricanAmerican |
8.946600E-01 |
| Caucasian-vs-Asian |
8.526000E-01 |
| AfricanAmerican-vs-Asian |
7.690400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.315200E-01 |
| Normal-vs-Female |
9.051800E-02 |
| Male-vs-Female |
5.443200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.553200E-01 |
| Normal-vs-Extreme_Weight |
3.904500E-02 |
| Normal-vs-Obese |
9.986600E-01 |
| Normal-vs-Extreme_Obese |
1.048030E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.809560E-01 |
| Normal_Weight-vs-Obese |
8.632800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.358000E-01 |
| Extreme_Weight-vs-Obese |
1.141400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.526000E-01 |
| Obese-vs-Extreme_Obese |
3.666400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.957620E-01 |
| Normal-vs-Age(41-60Yrs) |
5.123800E-01 |
| Normal-vs-Age(61-80Yrs) |
2.147600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.113980E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.560160E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.950300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.996100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.120200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.188030E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.515990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.738200E-01 |
| Normal-VS-Type2 PRCC |
5.944000E-01 |
| Normal-VS-KIRP CIMP |
2.412600E-01 |
| Normal-VS-Unclassified PRCC |
7.683000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.668400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.870010E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.961400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.490000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.528200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.846000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.207220E-01 |
| Normal-vs-N1 |
3.436200E-02 |
| Normal-vs-N2 |
8.725200E-01 |
| N0-vs-N1 |
1.373780E-02 |
| N0-vs-N2 |
4.780600E-01 |
| N1-vs-N2 |
4.104800E-01 |
|
|
